TriCor Indirect Purchasers' Attys Seek $22M In Fees
Attorneys for indirect purchaser plaintiffs in a class action accusing Abbott Laboratories and Fournier Industrie et Sante of blocking generic competition for cholesterol drug TriCor have asked a federal judge to...To view the full article, register now.
Already a subscriber? Click here to view full article